Inventiva (IVA) Assets Average (2019 - 2025)
Inventiva's (IVA) quarterly Assets Average came in at $101.4 billion in Q4 2025, up 137116.69% year-on-year from N/an in Q4 2024, and little changed quarter-over-quarter from $101.3 billion in Q2 2025.
Inventiva (IVA) Assets Average (2019 - 2025) Analysis & Trends
Inventiva's Assets Average history runs 7 years deep, the most recent figure standing at $101.4 billion for Q4 2025.
- On a quarterly basis, Assets Average rose 137116.69% year-over-year to $101.4 billion in Q4 2025; TTM through Dec 2025 was $101.4 billion, a 137116.69% increase from a year earlier, with the FY2025 full-year figure at $208.8 million, up 106.75% from the prior year.
- Assets Average steadied at $101.4 billion in Q4 2025 per IVA's latest filing, from $101.3 billion in the prior quarter.
- Across five years, Assets Average topped out at $101.4 billion in Q4 2025 and bottomed at $47.8 million in Q2 2024.
- The 5-year median for Assets Average is $140.4 million (2021), against an average of $22.6 billion.
- Across the five-year window, Assets Average sank 53.55% in 2022 and soared 212025.45% in 2025, its largest moves.
- Year by year, Assets Average stood at $140.4 million in 2021, then sank by 50.25% to $69.8 million in 2022, then declined by 21.38% to $54.9 million in 2023, then jumped by 34.64% to $73.9 million in 2024, then jumped by 137116.69% to $101.4 billion in 2025.
- Per Business Quant, the three latest IVA Assets Average figures stand at $101.4 billion (Q4 2025), $101.3 billion (Q2 2025), and $73.9 million (Q4 2024).
Peer Comparison
| # | Company | Market Cap | Enterprise Value | Gross Profit (Qtr) | Assets Avg. (Qtr) |
|---|---|---|---|---|---|
| 1 | Oculis Holding AG | 68,785.72 Bn | 68,785.72 Bn | - | 303.40 Mn |
| 2 | Nanobiotix | 1,895.57 Bn | 1,895.51 Bn | - | 65.01 Mn |
| 3 | BeOne Medicines | 471.35 Bn | 466.56 Bn | 1.35 Bn | 8.37 Bn |
| 4 | NuCana | 279.75 Bn | 279.75 Bn | - | 41.64 Mn |
| 5 | Vertex Pharmaceuticals | 120.24 Bn | 113.00 Bn | 2.59 Bn | 26.06 Bn |
| 6 | Regeneron Pharmaceuticals | 67.80 Bn | 59.04 Bn | 3.31 Bn | 40.71 Bn |
| 7 | Belite Bio | 62.51 Bn | 62.51 Bn | - | 795.91 Mn |
| 8 | Argenx Se | 57.38 Bn | 57.38 Bn | 1.41 Bn | - |
| 9 | Revolution Medicines | 37.78 Bn | 37.78 Bn | - | 2.30 Bn |
| 10 | Inventiva | 842.48 Mn | 842.48 Mn | - | 101.43 Bn |
Historic Data
Download Data| Date | Value |
|---|---|
| Dec 31, 2025 | 101.43 Bn |
| Jun 30, 2025 | 101.35 Bn |
| Dec 31, 2024 | 73.92 Mn |
| Jun 30, 2024 | 47.78 Mn |
| Dec 31, 2023 | 54.90 Mn |
| Jun 30, 2022 | 69.83 Mn |
| Dec 31, 2021 | 140.35 Mn |
| Jun 30, 2021 | 150.32 Mn |
| Mar 31, 2021 | 162.56 Mn |
| Dec 31, 2020 | 120.66 Mn |
| Dec 31, 2019 | 77.07 Mn |